Of note, the distribution of the participants of the cohort (13 participants tau PET‐positive who were also amyloid PET‐positive), among the 35 amyloid‐positive participants, suggests that most participants were in an earlier, amyloid‐predominant stage of AD. Here, MAPT is linked to Alzheimer disease.